Main ContentTraumatic Cervical Spinal Cord Injury
Study title
Phase 2b/3 double blind randomized placebo controlled multicenter study to assess the efficacy and safety of VX-210 in subjects with acute traumatic cervical spinal cord injury
- Principal Investigator: Dr. Louis Harkey
Purpose
This study will assess safety and efficacy of an experimental drug in patients with spinal cord injuries.
Who can participate
Those eligible to participate in this study include:
- Adults ges 18-75 with an acute spinal cord injury involving cervical spine
For more information
- Heather Vaughn
University of Mississippi Medical Center
2500 N. State St.
Jackson MS 39216
(601) 815-8724 - IRB Number: 2017-0197